1. Home
  2. MTA vs BVS Comparison

MTA vs BVS Comparison

Compare MTA & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metalla Royalty & Streaming Ltd.

MTA

Metalla Royalty & Streaming Ltd.

HOLD

Current Price

$7.51

Market Cap

766.4M

Sector

N/A

ML Signal

HOLD

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$10.64

Market Cap

617.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTA
BVS
Founded
1983
2011
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
766.4M
617.1M
IPO Year
2017
2016

Fundamental Metrics

Financial Performance
Metric
MTA
BVS
Price
$7.51
$10.64
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$9.00
$14.00
AVG Volume (30 Days)
356.7K
435.5K
Earning Date
05-15-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
163.46
EPS
N/A
0.04
Revenue
N/A
$568,087,000.00
Revenue This Year
$81.63
$7.52
Revenue Next Year
$62.44
$7.06
P/E Ratio
N/A
$265.75
Revenue Growth
N/A
N/A
52 Week Low
$2.83
$5.81
52 Week High
$9.25
$11.25

Technical Indicators

Market Signals
Indicator
MTA
BVS
Relative Strength Index (RSI) 58.91 60.36
Support Level $7.08 $8.27
Resistance Level $7.73 $11.00
Average True Range (ATR) 0.33 0.56
MACD 0.11 -0.01
Stochastic Oscillator 80.43 62.64

Price Performance

Historical Comparison
MTA
BVS

About MTA Metalla Royalty & Streaming Ltd.

Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company, which engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests.

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Share on Social Networks: